HEADER TRANSFERASE 05-MAY-99 3BIF TITLE 6-PHOSPHOFRUCTO-2-KINASE/FRUCTOSE-2,6-BISPHOSPHATASE EMPTY 6-PF-2K TITLE 2 ACTIVE SITE COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTEIN (6-PHOSPHOFRUCTO-2-KINASE/ FRUCTOSE-2,6- COMPND 3 BISPHOSPHATASE); COMPND 4 CHAIN: A; COMPND 5 EC: 2.7.1.105; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES; COMPND 8 OTHER_DETAILS: BIFUNCTIONAL ENZYME, ALSO EC 3.1.3.46 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: RATTUS NORVEGICUS; SOURCE 3 ORGANISM_COMMON: NORWAY RAT; SOURCE 4 ORGANISM_TAXID: 10116; SOURCE 5 CELL_LINE: BL21; SOURCE 6 ORGAN: TESTIS; SOURCE 7 GENE: RT2K; SOURCE 8 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 9 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 10 EXPRESSION_SYSTEM_CELL_LINE: BL21; SOURCE 11 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 12 EXPRESSION_SYSTEM_PLASMID: PT7-7; SOURCE 13 EXPRESSION_SYSTEM_GENE: RT2K KEYWDS KINASE, PHOSPHOTRANSFERASE, PHOSPHATASE, HYDROLASE (PHOSPHO), KEYWDS 2 GLYCOLYSIS, BIFUNCTIONAL ENZYME, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR M.H.YUEN,C.A.HASEMANN REVDAT 7 30-AUG-23 3BIF 1 REMARK REVDAT 6 03-NOV-21 3BIF 1 SEQADV HETSYN REVDAT 5 29-JUL-20 3BIF 1 COMPND REMARK HETNAM SITE REVDAT 4 27-NOV-19 3BIF 1 JRNL REVDAT 3 24-FEB-09 3BIF 1 VERSN REVDAT 2 01-APR-03 3BIF 1 JRNL REVDAT 1 29-SEP-99 3BIF 0 JRNL AUTH M.H.YUEN,X.L.WANG,H.MIZUGUCHI,K.UYEDA,C.A.HASEMANN JRNL TITL A SWITCH IN THE KINASE DOMAIN OF RAT TESTIS JRNL TITL 2 6-PHOSPHOFRUCTO-2-KINASE/FRUCTOSE-2,6-BISPHOSPHATASE. JRNL REF BIOCHEMISTRY V. 38 12333 1999 JRNL REFN ISSN 0006-2960 JRNL PMID 10493801 JRNL DOI 10.1021/BI991268+ REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH C.A.HASEMANN,E.S.ISTVAN,K.UYEDA,J.DEISENHOFER REMARK 1 TITL THE CRYSTAL STRUCTURE OF THE BIFUNCTIONAL ENZYME REMARK 1 TITL 2 6-PHOSPHOFRUCTO-2-KINASE/FRUCTOSE-2,6-BISPHOSPHATASE REVEALS REMARK 1 TITL 3 DISTINCT DOMAIN HOMOLOGIES. REMARK 1 REF STRUCTURE V. 4 1017 1996 REMARK 1 REFN ISSN 0969-2126 REMARK 1 PMID 8805587 REMARK 1 DOI 10.1016/S0969-2126(96)00109-8 REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 3.851 REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 1.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 1000000.000 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0001 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 85.2 REMARK 3 NUMBER OF REFLECTIONS : 23883 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.197 REMARK 3 FREE R VALUE : 0.243 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2434 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.005 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 8 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.30 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.40 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 78.90 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2457 REMARK 3 BIN R VALUE (WORKING SET) : 0.3190 REMARK 3 BIN FREE R VALUE : 0.3580 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 10.00 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 276 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.021 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3506 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 58 REMARK 3 SOLVENT ATOMS : 187 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 39.90 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 39.00 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 1.500 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 21.60 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.260 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 3.870 ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : 5.320 ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : 5.480 ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : 7.390 ; NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : ENGH & HUBER REMARK 3 PARAMETER FILE 2 : NULL REMARK 3 TOPOLOGY FILE 1 : ENGH & HUBER REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REMARK 3 THE N-TERMINAL 36 AMINO ACIDS OF THE PROTEIN WERE NOT REMARK 3 VISIBLE IN THE ELECTRON DENSITY. PROTEIN SEQUENCE ANALYSIS REMARK 3 OF A REDISSOLVED CRYSTAL CONFIRMED THE PRESENCE OF THE REMARK 3 N-TERMINUS IN THE CRYSTALS. THE CONCLUSION IS THAT REMARK 3 THE N-TERMINAL 36 AMINO ACIDS ARE DISORDERED. REMARK 4 REMARK 4 3BIF COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 06-MAY-99. REMARK 100 THE DEPOSITION ID IS D_1000001007. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 09-OCT-97 REMARK 200 TEMPERATURE (KELVIN) : 120 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU200 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : MIRRORS REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MACSCIENCE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 23883 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 88.1 REMARK 200 DATA REDUNDANCY : 2.640 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.03900 REMARK 200 FOR THE DATA SET : 36.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.35 REMARK 200 COMPLETENESS FOR SHELL (%) : 84.9 REMARK 200 DATA REDUNDANCY IN SHELL : 2.30 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.15000 REMARK 200 FOR SHELL : 7.160 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: X-PLOR REMARK 200 STARTING MODEL: 1BIF REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 57.60 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.97 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PROTEIN WAS CRYSTALLIZED FROM 50MM REMARK 280 SUCCINATE, PH 5.5, 50MM TRIS-PO4, PH 7.5, 11% PEG 4000, 100UM REMARK 280 EDTA, 10MM DTT, 10% GLYCEROL, 3MM MGCL2., PH 7.0 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 53.35000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 54.35000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 53.35000 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 54.35000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 -91.21362 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 110.65097 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA A 1 REMARK 465 SER A 2 REMARK 465 PRO A 3 REMARK 465 ARG A 4 REMARK 465 GLU A 5 REMARK 465 LEU A 6 REMARK 465 THR A 7 REMARK 465 GLN A 8 REMARK 465 ASN A 9 REMARK 465 PRO A 10 REMARK 465 LEU A 11 REMARK 465 LYS A 12 REMARK 465 LYS A 13 REMARK 465 ILE A 14 REMARK 465 PHE A 15 REMARK 465 MET A 16 REMARK 465 PRO A 17 REMARK 465 TYR A 18 REMARK 465 SER A 19 REMARK 465 ASN A 20 REMARK 465 GLY A 21 REMARK 465 ARG A 22 REMARK 465 PRO A 23 REMARK 465 ALA A 24 REMARK 465 LEU A 25 REMARK 465 HIS A 26 REMARK 465 ALA A 27 REMARK 465 SER A 28 REMARK 465 GLN A 29 REMARK 465 ARG A 30 REMARK 465 GLY A 31 REMARK 465 VAL A 32 REMARK 465 CYS A 33 REMARK 465 MET A 34 REMARK 465 THR A 35 REMARK 465 ASN A 36 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 LEU A 409 CA - CB - CG ANGL. DEV. = 15.8 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 83 18.78 58.83 REMARK 500 ASP A 219 91.02 62.64 REMARK 500 VAL A 220 107.10 -19.29 REMARK 500 GLN A 222 -64.47 -94.74 REMARK 500 ARG A 228 56.91 38.65 REMARK 500 ASP A 295 71.27 41.40 REMARK 500 GLU A 383 -113.77 -114.68 REMARK 500 CYS A 389 -138.66 -132.35 REMARK 500 CYS A 429 119.72 -166.49 REMARK 500 LEU A 436 44.32 -89.46 REMARK 500 ASN A 437 44.01 39.28 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: S1 REMARK 800 EVIDENCE_CODE: AUTHOR REMARK 800 SITE_DESCRIPTION: WALKER-A MOTIF (GXXGXGKT), PART OF THE CLASSICAL REMARK 800 MONONUCLEOTIDE BINDING MOTIF. REMARK 800 REMARK 800 SITE_IDENTIFIER: S2 REMARK 800 EVIDENCE_CODE: AUTHOR REMARK 800 SITE_DESCRIPTION: WALKER-B MOTIF (ZZZZD, Z=HYDROPHOBIC), PART OF REMARK 800 THE CLASSICAL MONONUCLEOTIDE BINDING MOTIF. ASP 128 SERVES AS A REMARK 800 LIGAND TO THE MG OF MG-ATP. REMARK 800 REMARK 800 SITE_IDENTIFIER: S3 REMARK 800 EVIDENCE_CODE: AUTHOR REMARK 800 SITE_DESCRIPTION: CATALYTIC TRIAD FOR THE FRUCTOSE-2,6 REMARK 800 -BISPHOSPHATASE REACTION. DBREF 3BIF A 1 468 UNP P25114 F264_RAT 1 468 SEQADV 3BIF PHE A 64 UNP P25114 TRP 64 ENGINEERED MUTATION SEQADV 3BIF PHE A 299 UNP P25114 TRP 299 ENGINEERED MUTATION SEQADV 3BIF PHE A 320 UNP P25114 TRP 320 ENGINEERED MUTATION SEQRES 1 A 468 ALA SER PRO ARG GLU LEU THR GLN ASN PRO LEU LYS LYS SEQRES 2 A 468 ILE PHE MET PRO TYR SER ASN GLY ARG PRO ALA LEU HIS SEQRES 3 A 468 ALA SER GLN ARG GLY VAL CYS MET THR ASN CYS PRO THR SEQRES 4 A 468 LEU ILE VAL MET VAL GLY LEU PRO ALA ARG GLY LYS THR SEQRES 5 A 468 TYR ILE SER LYS LYS LEU THR ARG TYR LEU ASN PHE ILE SEQRES 6 A 468 GLY VAL PRO THR ARG GLU PHE ASN VAL GLY GLN TYR ARG SEQRES 7 A 468 ARG ASP MET VAL LYS THR TYR LYS SER PHE GLU PHE PHE SEQRES 8 A 468 LEU PRO ASP ASN GLU GLU GLY LEU LYS ILE ARG LYS GLN SEQRES 9 A 468 CYS ALA LEU ALA ALA LEU ASN ASP VAL ARG LYS PHE LEU SEQRES 10 A 468 SER GLU GLU GLY GLY HIS VAL ALA VAL PHE ASP ALA THR SEQRES 11 A 468 ASN THR THR ARG GLU ARG ARG ALA MET ILE PHE ASN PHE SEQRES 12 A 468 GLY GLU GLN ASN GLY TYR LYS THR PHE PHE VAL GLU SER SEQRES 13 A 468 ILE CYS VAL ASP PRO GLU VAL ILE ALA ALA ASN ILE VAL SEQRES 14 A 468 GLN VAL LYS LEU GLY SER PRO ASP TYR VAL ASN ARG ASP SEQRES 15 A 468 SER ASP GLU ALA THR GLU ASP PHE MET ARG ARG ILE GLU SEQRES 16 A 468 CYS TYR GLU ASN SER TYR GLU SER LEU ASP GLU GLU GLN SEQRES 17 A 468 ASP ARG ASP LEU SER TYR ILE LYS ILE MET ASP VAL GLY SEQRES 18 A 468 GLN SER TYR VAL VAL ASN ARG VAL ALA ASP HIS ILE GLN SEQRES 19 A 468 SER ARG ILE VAL TYR TYR LEU MET ASN ILE HIS VAL THR SEQRES 20 A 468 PRO ARG SER ILE TYR LEU CYS ARG HIS GLY GLU SER GLU SEQRES 21 A 468 LEU ASN LEU LYS GLY ARG ILE GLY GLY ASP PRO GLY LEU SEQRES 22 A 468 SER PRO ARG GLY ARG GLU PHE SER LYS HIS LEU ALA GLN SEQRES 23 A 468 PHE ILE SER ASP GLN ASN ILE LYS ASP LEU LYS VAL PHE SEQRES 24 A 468 THR SER GLN MET LYS ARG THR ILE GLN THR ALA GLU ALA SEQRES 25 A 468 LEU SER VAL PRO TYR GLU GLN PHE LYS VAL LEU ASN GLU SEQRES 26 A 468 ILE ASP ALA GLY VAL CYS GLU GLU MET THR TYR GLU GLU SEQRES 27 A 468 ILE GLN ASP HIS TYR PRO LEU GLU PHE ALA LEU ARG ASP SEQRES 28 A 468 GLN ASP LYS TYR ARG TYR ARG TYR PRO LYS GLY GLU SER SEQRES 29 A 468 TYR GLU ASP LEU VAL GLN ARG LEU GLU PRO VAL ILE MET SEQRES 30 A 468 GLU LEU GLU ARG GLN GLU ASN VAL LEU VAL ILE CYS HIS SEQRES 31 A 468 GLN ALA VAL MET ARG CYS LEU LEU ALA TYR PHE LEU ASP SEQRES 32 A 468 LYS ALA ALA GLU GLU LEU PRO TYR LEU LYS CYS PRO LEU SEQRES 33 A 468 HIS THR VAL LEU LYS LEU THR PRO VAL ALA TYR GLY CYS SEQRES 34 A 468 LYS VAL GLU SER ILE PHE LEU ASN VAL ALA ALA VAL ASN SEQRES 35 A 468 THR HIS ARG ASP ARG PRO GLN ASN VAL ASP ILE SER ARG SEQRES 36 A 468 PRO SER GLU GLU ALA LEU VAL THR VAL PRO ALA HIS GLN HET BOG A 510 20 HET BOG A 525 20 HET PO4 A 515 5 HET PO4 A 520 5 HET SIN A 505 8 HETNAM BOG OCTYL BETA-D-GLUCOPYRANOSIDE HETNAM PO4 PHOSPHATE ION HETNAM SIN SUCCINIC ACID HETSYN BOG BETA-OCTYLGLUCOSIDE; OCTYL BETA-D-GLUCOSIDE; OCTYL D- HETSYN 2 BOG GLUCOSIDE; OCTYL GLUCOSIDE FORMUL 2 BOG 2(C14 H28 O6) FORMUL 4 PO4 2(O4 P 3-) FORMUL 6 SIN C4 H6 O4 FORMUL 7 HOH *187(H2 O) HELIX 1 1 GLY A 50 ILE A 65 1 16 HELIX 2 2 VAL A 74 LYS A 83 1 10 HELIX 3 3 SER A 87 LEU A 92 5 6 HELIX 4 4 ASN A 95 GLU A 119 1 25 HELIX 5 5 THR A 133 ASN A 147 1 15 HELIX 6 6 ASP A 160 SER A 175 1 16 HELIX 7 7 PRO A 176 VAL A 179 5 4 HELIX 8 8 ASP A 182 ASN A 199 1 18 HELIX 9 9 ASP A 231 MET A 242 1 12 HELIX 10 10 SER A 259 LYS A 264 1 6 HELIX 11 11 SER A 274 ASN A 292 1 19 HELIX 12 12 MET A 303 GLU A 311 1 9 HELIX 13 13 LYS A 321 ASN A 324 5 4 HELIX 14 14 ALA A 328 GLU A 332 5 5 HELIX 15 15 THR A 335 TYR A 343 1 9 HELIX 16 16 TYR A 343 ASP A 353 1 11 HELIX 17 17 SER A 364 LEU A 372 1 9 HELIX 18 18 LEU A 372 GLN A 382 1 11 HELIX 19 19 HIS A 390 ASP A 403 1 14 HELIX 20 20 GLU A 408 LEU A 412 5 5 HELIX 21 21 PRO A 456 LEU A 461 1 6 SHEET 1 A 6 THR A 69 ASN A 73 0 SHEET 2 A 6 VAL A 124 ASP A 128 1 O VAL A 124 N ARG A 70 SHEET 3 A 6 THR A 39 VAL A 44 1 O THR A 39 N ALA A 125 SHEET 4 A 6 LYS A 150 ILE A 157 1 O LYS A 150 N LEU A 40 SHEET 5 A 6 TYR A 214 MET A 218 1 N ILE A 215 O PHE A 153 SHEET 6 A 6 SER A 223 ASN A 227 -1 O SER A 223 N MET A 218 SHEET 1 B 6 TYR A 317 GLN A 319 0 SHEET 2 B 6 LYS A 297 THR A 300 1 O VAL A 298 N GLU A 318 SHEET 3 B 6 VAL A 385 CYS A 389 1 N LEU A 386 O LYS A 297 SHEET 4 B 6 ILE A 251 ARG A 255 1 N TYR A 252 O VAL A 385 SHEET 5 B 6 THR A 418 PRO A 424 -1 N LEU A 420 O LEU A 253 SHEET 6 B 6 CYS A 429 PHE A 435 -1 O LYS A 430 N THR A 423 SITE 1 S1 8 GLY A 45 LEU A 46 PRO A 47 ALA A 48 SITE 2 S1 8 ARG A 49 GLY A 50 LYS A 51 THR A 52 SITE 1 S2 5 VAL A 124 ALA A 125 VAL A 126 PHE A 127 SITE 2 S2 5 ASP A 128 SITE 1 S3 3 HIS A 256 GLU A 325 HIS A 390 CRYST1 106.700 108.700 71.700 90.00 129.50 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009372 0.000000 0.007726 0.00000 SCALE2 0.000000 0.009200 0.000000 0.00000 SCALE3 0.000000 0.000000 0.018075 0.00000